Log in

NASDAQ:REGNRegeneron Pharmaceuticals SEC Filings & 10K Form

$578.21
+34.20 (+6.29 %)
(As of 05/28/2020 04:00 PM ET)
Add
Compare
Today's Range
$546.13
Now: $578.21
$583.03
50-Day Range
$501.51
MA: $549.49
$577.12
52-Week Range
$271.37
Now: $578.21
$583.54
Volume7.86 million shs
Average Volume1.29 million shs
Market Capitalization$63.61 billion
P/E Ratio29.06
Dividend YieldN/A
Beta0.53

SEC Filings

Regeneron Pharmaceuticals (NASDAQ:REGN) SEC Filings

DateFilerForm TypeView
05/28/2020
2:50 PM
Regeneron Pharmaceuticals (Filer)
Form 424B3
05/26/2020
5:16 AM
Regeneron Pharmaceuticals (Filer)
Form 424B3
05/26/2020
5:11 AM
Regeneron Pharmaceuticals (Subject)
Sanofi (Filed by)
Form FWP
05/26/2020
5:08 AM
Regeneron Pharmaceuticals (Subject)
Form FWP
05/22/2020
5:21 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:21 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
8:01 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
8:00 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:04 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
5:22 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
6:51 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2020
6:29 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2020
6:27 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2020
6:26 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2020
6:23 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
3:02 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
5:06 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2020
3:50 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
3:49 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
5:49 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
3:12 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
5:14 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:10 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:45 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:04 AM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2020
6:33 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
4:06 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
8:14 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
3:07 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
3:05 PM
POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
5:03 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
4:43 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:44 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:41 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:38 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2019
3:08 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:07 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:06 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:03 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
4:02 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
6:47 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
12:58 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
09/12/2019
4:00 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
6:55 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
4:20 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
3:16 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
7:42 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:02 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
9:42 AM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
05/09/2019
3:40 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
05/07/2019
4:00 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K/A
05/07/2019
1:03 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
05/07/2019
6:50 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:01 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:05 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
04/26/2019
3:02 PM
Regeneron Pharmaceuticals (Filer)
Form DEF 14A
04/18/2019
6:04 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
4:12 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2019
3:03 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
7:19 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
11:02 AM
FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2019
2:14 PM
Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2019
3:12 PM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2019
6:48 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2019
4:01 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
3:06 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:13 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:09 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:08 PM
COLES N ANTHONY (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:07 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:05 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:04 PM
Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
4:36 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
3:08 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
3:02 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:49 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:21 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:19 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:18 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:12 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:08 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:06 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:05 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
3:31 PM
Regeneron Pharmaceuticals (Filer)
Form S-3ASR
11/06/2018
6:56 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
6:39 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
6:45 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2018
3:06 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:35 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
3:05 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2018
3:04 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
4:01 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
3:02 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.